Navigation Links
Rules-Based Medicine, Inc. (RBM) Partners with Institut Pasteur to Boost Innovation in Translational Research
Date:5/12/2011

y and cardiology. RBM's initial molecular diagnostic test, VeriPsych™, is a blood-based test that aids in the confirmation of diagnosis of recent-onset schizophrenia by evaluating a proprietary set of 51 biomarkers. RBM also offers innovative and proprietary ex vivo testing systems such as TruCulture®, the first fully-closed, reproducible whole blood culture system.

More information about RBM is located at www.rulesbasedmedicine.com.

About Institut Pasteur

Created in 1887 by Louis Pasteur, the Institut Pasteur is a private, public-interest foundation and an internationally recognized center for biomedical research. Its mission is to contribute to disease prevention and eradication in France and around the world through scientific and medical research, education and public health programs. Close to 2,600 people work at its Paris campus.

Along with research on living science, a large part of its work is devoted to the study of infectious disease, genetic disease, neuro-degenerative disease and some cancers. The Institut Pasteur is the hub of an international network of 32 institutes on every continent. Ten of its researchers have received the Nobel Prize in Medicine since its establishment.

More information about Institut Pasteur is located at www.pasteur.fr

About the LabEx Laboratories of Excellence grants

The LabEx grant program is part of the French government's Invest in the Future economic stimulus plan. The program aims to provide world-class labs with the resources they need to compete at an international level, attract top-tier faculty and researchers from around the world, and implement high-level integrated policies encompassing research, education, and technology transfer. A total of euro 1 billion will be distributed under LabEx grants, including euro 100 million of direct funding and euro 900 mill
'/>"/>

SOURCE Rules-Based Medicine, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Rules-Based Medicine Launches OncologyMAP® to Advance Cancer-Related Drug and Diagnostic Development
2. Rules-Based Medicine, Inc. Launches DiscoveryMAP(TM) Service for Drug and Diagnostic Development
3. Rules-Based Medicine, Inc. Launches Human Kidney Damage Biomarker Panel
4. Penn-led collaboration mimics library of bio-membranes for use in nanomedicine, drug delivery
5. Tianjin International Joint Academy of Biotechnology and Medicine, Genzyme Enter into Strategic Partnership
6. Harbinger Research Initiates Coverage on China Baicaotang Medicine, Ltd.
7. Genedata and the Institute of Experimental Medicine, Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project
8. Council for American Medical Innovation Brings U.S. Leaders in Medicine, Biotechnology and Discovery Together in Chicago for Best and Brightest Forum on Medical Innovation
9. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
10. Aperio Partners with Definiens to Market Definiens Tissue Studio for Advanced Image Analysis
11. John McKearn, Ph.D., Promoted to Managing Director of RiverVest Venture Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... This news release is available in German . ... all too well: with the naked eye, you can see ... bird in the blur of branches through the telephoto lens ... story for researchers who are looking to study proteins, the ... at ETH Zurich,s Institute for Molecular Systems Biology, and her ...
(Date:5/17/2013)... New interactive learning forums ... leaders of the medical device industry at the ... expo, from June 18-20 in Philadelphia ... ) , These all-new MedTech ... practical presentations and implementable solutions on the most ...
(Date:5/17/2013)... , May 17, 2013  Insero Health, Inc., a ... in epilepsy and related neurological disorders, is today reporting ... lead compound INS001 in patients with drug-resistant epilepsy.  The ... Device Trials (AED) Xll meeting by Dr. ... Chairman of Insero,s Scientific Advisory Board.  In this study, ...
(Date:5/17/2013)... Rust removal is one of home maintenance's essential processes. Without ... To help rust contractors make it less expensive, My Cleaning ... it called Rusterizer. It announced that for this month, ... Cleaning Products explained that rust could damage items in two ... The first one, it said, happens when rust forms in ...
Breaking Biology Technology:Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount 2
... Germany, May 3, 2012 , Point-of-Care ... Health program funded by Bill & Melinda Gates Foundation and ... and technologies will aid effort to create a low-cost portable ... , Development expected to be completed by ...
... for Clinical Research, Inc., a company focused on early ... record growth in the number of clinical trials in ... the number of mid-size biotech and off-shore clients, while ... driven by a strong demand for Phase I and ...
... Silence Therapeutics Plc (AIM: SLN), a leading international ... Quark Pharmaceuticals , has announced it has amended its existing ... to perform a Phase 2a clinical study to assess the ... function in patients with moderate and advanced Open-Angle Glaucoma (OAG). ...
Cached Biology Technology:QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to World's Poorest Countries 2QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to World's Poorest Countries 3QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to World's Poorest Countries 4QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to World's Poorest Countries 5Profil Institute Reports Record Growth in Number of Clinical Trials in the Pipeline 2Profil Institute Reports Record Growth in Number of Clinical Trials in the Pipeline 3Silence Therapeutics' Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silence's AtuRNAi in a New Indication 2Silence Therapeutics' Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silence's AtuRNAi in a New Indication 3Silence Therapeutics' Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silence's AtuRNAi in a New Indication 4Silence Therapeutics' Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silence's AtuRNAi in a New Indication 5
(Date:5/17/2013)... New Jersey, and City University of New York have ... that effectively clears organisms to be viewed under microscopes. ... which is one of the few high-quality clearing solutions ... Drug Enforcement Administration (DEA) due to its use as ... vital for viewing organisms under a microscope. Without them, ...
(Date:5/17/2013)... new Dartmouth College study finds human-caused climate change ... tropical lizards, contradicting a host of recent studies ... warming planet. , The findings, which appear in ... new hope for survival of a creature thought ... predictions that tropical cold-blooded animals, especially forest lizards, ...
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) Program ... Society for Developmental Biology (SDB) 72nd Annual Meeting ... awards are meant to promote the entry of ... the mainstream of the basic science community and ... the SDB 2013 Annual Meeting. , Awards are ...
Breaking Biology News(10 mins):New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3Climate change may have little impact on tropical lizards 2
... Logic, and Nano-Biofuel Cells," will be the focus of ... Innovation Summit 10 http://www.nsti.org/events/NNI/ , at the ... celebrates the 10th anniversary of the national nanotechnology initiative. ... New Jersey selected for this exposition featuring practical applications ...
... A combination of lapatinib, trastuzumab and paclitaxel significantly improved ... with HER2-positive breast cancers, according to data presented at ... held Dec. 8-12. Full results were presented at the ... at 8:00 a.m. CT. Reporters who cannot ...
... its current session, the Federation of American Societies for ... urge their Senators and Representatives to pass a fiscal ... billion funding increase for the National Institutes of Health ... across the country sent nearly 9,400 messages to Capitol ...
Cached Biology News:Directed self-assembly of vertical nanotubes for biosensors, logic, nano-biofuel cells 2Combination therapy reduced HER2-positive breast cancers 2
... are predominantly used for labeling proteins, the ... peptides and nucleotides because they give better ... required in the conjugation processes. 5-TAMRA is ... peptides and proteins. 6-TAMRA is predominately used ...
anti-Lactate Dehydrogenase...
Mouse monoclonal [6E10] to LAP2 ( Abpromise for all tested applications). entrezGeneID: 7112 SwissProtID: P42166...
Alkali soluble casein is the recommended blot blocking reagent for use with the HisTag Monoclonal Antibody (Novagen) on Western blots....
Biology Products: